Skip to content

SCHEDULE 13D/AAccepted Feb 26, 7:22 PM ET

Bolt Biotherapeutics, Inc. SCHEDULE 13D/A

Pivotal bioVenture Partners Fund I, L.P.

Accepted (ET)

7:22 PM

Feb 26, 2026

Filed

Feb 26, 2026

Documents

2

Size

62.1 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.